Hybrid Conferencee

International Symposium on Oncology, Immunotherapy and Biomarkers (ISOIB - 27)

17th - 18th March 2027 | Pretoria, South Africa
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Expand the Academic Reach of Your Research - a Q1-ranked and Scopus-indexed journal publication opportunity

Journal consideration and publication are subject to editorial review, peer review and applicable journal policies.

Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Pretoria. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Pretoria event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Pretoria conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Pretoria, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Pretoria."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Call for Paper

The ISOIB aims to explore emerging trends and future directions in research and innovation. It provides a collaborative platform for researchers and professionals to share ideas that shape the future of their respective domains.

The conference highlights advancements in Oncology, encouraging innovative, solution-oriented research that addresses global challenges and technological evolution.

Authors are invited to submit papers addressing, but not limited to, the following areas:

01
Biomarkers in cancer diagnosis and treatment
02
Immunotherapy and its clinical applications
03
Role of precision medicine in oncology
04
Emerging trends in cancer immunotherapy
05
Biomarker discovery and validation
06
Challenges in immunotherapy implementation
07
Patient selection for immunotherapy
08
Combination therapies with immunotherapy
09
Ethical issues in biomarker research
10
Impact of biomarkers on treatment outcomes
11
Innovative technologies in biomarker analysis
12
Clinical trials for immunotherapeutic agents
13
Role of the immune system in cancer
14
Biomarkers for early cancer detection
15
Patient perspectives on immunotherapy
16
Regulatory considerations for biomarker use
17
Future directions in immunotherapy research
18
Collaboration between academia and industry
19
Health disparities in access to immunotherapy
20
Integrating biomarkers into clinical practice